Moderna, Inc. (MRNA)

The payment is part of a larger ... Moderna (MRNA) agreed to settle claims tied to the use of lipid nanoparticle technology in its COVID-19 vaccines. The settlement helped Roivant post net income of $355.7 million for the quarter, compared with a loss of $252.4 million a year earlier. Earnings per s…

The Food and Drug Administration is eyeing a meeting on June 18 to discuss mRNA-1010.

While the pathogen appears unlikely to trigger a pandemic, analysts see potential for Moderna to build goodwill amid a period of political pressure on vaccine manufacturers.

The offer of the ETP Securities described in these Final Terms in conditional on the ETP Securities being admitted to trading on the Main Market of the London Stock Exchange. The offer of these ETP...

Flagship Pioneering, tied to Moderna director Noubar Afeyan, exercised options for 9,263 MRNA shares at $19.15 then sold 9,263 shares at $46.84, leaving 3,924 shares indirectly held.